SCHEMBL30898009

SCHEMBL30898009

Cc1cc(Br)cc(N)c1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.40
TSHR P16473 2/20 0.40
MAPK1 P28482 1/20 0.40
ALDH1A1 P00352 4/20 0.36
TDP1 Q9NUW8 2/20 0.36
UHRF1 Q96T88 1/20 0.33
CYP1A2 P05177 1/20 0.33
ALOX15 P16050 1/20 0.33
CASP7 P55210 1/20 0.33
HIF1A Q16665 1/20 0.33
HSD17B10 Q99714 1/20 0.33
S100B P04271 1/20 0.32
TERT O14746 1/20 0.32
IDO1 P14902 1/20 0.31
TDO2 P48775 1/20 0.31
CASP1 P29466 1/20 0.31
CD44 P16070 1/20 0.31
MEN1 O00255 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16550078 1.00 CYP3A4 (0.40) CYP3A4TSHRMAPK1ALDH1A1TDP1
SCHEMBL1144875 0.82 NQO2 (0.35) CYP3A4TSHRMAPK1ALDH1A1TDP1
SCHEMBL13550087 0.75 CYP3A4 (0.38) CYP3A4TSHRALDH1A1TDP1ALOX15
SCHEMBL159075 0.75 ALDH1A1 (0.43) CYP3A4TSHRMAPK1ALDH1A1TDP1
SCHEMBL29865173 0.75 DGAT1 (0.34) ALDH1A1IDO1TDO2
SCHEMBL25162025 0.75 ALDH1A1 (0.52) CYP3A4TSHRMAPK1ALDH1A1TDP1
SCHEMBL15709089 0.75 CYP3A4 (0.38) CYP3A4TSHRTDP1IDO1TDO2
SCHEMBL13550061 0.75 RAPGEF4 (0.34) NPC1RAB9ANQO2
SCHEMBL6670544 0.75 CYP3A4 (0.43) CYP3A4TSHRMAPK1ALDH1A1TDP1
SCHEMBL29603436 0.75 RAPGEF4 (0.34) NPC1RAB9ANQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059040-A1 MUTANT KRAS MODULATORS AND USES THEREOF NEWAVE PHARMACEUTICAL INC. (US) 2025-03-20 WO disclosed
WO-2024104453-A1 FUSED TRICYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL USE THEREOF 江苏恒瑞医药股份有限公司 2024-05-23 WO disclosed